However, compared with general invasive breast cancer, ER and PR of NECB are often highly expressed, and HER-2 is often low-expressed,[20] which proves that the disease is mostly hormone-receptor-dependent type of breast cancer, and endocrine therapy is of great importance. This evidence concerns the gene ERBB2 and invasive breast carcinoma.